oral glp-1 agonist approved Comparing Ozempic, Wegovy and Other Drugs Oral Semaglutide Approved to Reduce
Description
Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis
Trulicity (dulaglutide) and Ozempic (semaglutide) are both medications used to treat type 2 diabetes, and they belong to the same class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
doi: 10.3389/fncel.2019.00017
SOURCE: FDA, news release, Dec
One study (SURPASS-2) specifically compared Mounjaro 5 mg, 10 mg, and 15 mg to low-dose semaglutide (1 mg) in people with type 2 diabetes
His A1c has decreased to 5.6%
